Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects-Reference-Cited by-同舟云学术

Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects

Published:2017-12-01 Issue:67 Volume:8 Page:111482-111494
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ding Guowen¹,Wang Yafeng²,Chen Yu³,Yin Jun¹,Liu Chao¹,Fan Yu⁴,Qiu Hao⁵,Tang Weifeng⁶,Chen Shuchen⁶

Affiliation:

1. Department of Cardiothoracic Surgery, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China

2. Department of Cardiology, The People’s Hospital of Xishuangbanna Dai Autonomous Prefecture, Jinghong, Yunnan Province, China

3. Department of Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian Province, China

4. Department of Medical Oncology, Affiliated People’s Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China

5. Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China

6. Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of Association Between PDCD-1 Polymorphisms and Colorectal Cancer Risk: A Case-Control Study;Immunological Investigations;2022-05-02

2. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects;Bioscience Reports;2020-02

3. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case–control study;Bioscience Reports;2019-11

4. Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells;OncoTargets and Therapy;2018-05